Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease

Wagner, Abram L.; Shrivastwa, Nijika; Potter, Rachel; Lyon-Callo, Sarah; Boulton, Matthew L.

doi:10.1016/j.jpeds.2018.01.023

Cited by 11 publications

(10 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…39 IISs are also used to assess population vaccination coverage among children, adolescents, adults, and persons in highrisk groups. 28,[48][49][50][51] To our knowledge, our study is the first to use an IIS to evaluate vaccination coverage among persons who inject drugs. This method could be used by other jurisdictions with adult vaccination records in their IISs.…”

Section: Discussionmentioning

confidence: 99%

Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection

et al. 2019

View full text Add to dashboard Cite

Objectives: Despite recommendations for vaccination against hepatitis A virus (HAV) and hepatitis B virus (HBV) for all adults at increased risk of infection, several US states have reported increases in HAV and HBV infections among persons who inject drugs. We investigated hepatitis A and hepatitis B vaccination coverage among a sample of persons who reported injecting drugs and had evidence of hepatitis C virus (HCV) infection. Methods: We searched the Wisconsin Immunization Registry for the vaccination records of persons who underwent HCV testing at syringe services programs from January 1 through August 31, 2018, and were reported to the Wisconsin Division of Public Health as having positive HCV antibody test results and a history of injection drug use. We calculated the percentage of persons who were vaccinated according to national recommendations. Results: Of 215 persons reported, 204 (94.9%) had a client record in the Wisconsin Immunization Registry. Of these 204 persons, 66 (32.4%) had received ≥1 dose of hepatitis A vaccine, 46 (22.5%) had received 2 doses of hepatitis A vaccine, and 115 (56.4%) had received 3 doses of hepatitis B vaccine. Hepatitis B vaccine coverage decreased with increasing age, from 88.0% (22 of 25) among adults aged 20-24 to 30.3% (10 of 33) among adults aged 35-39. Conclusions: These findings suggest that most persons who inject drugs in Wisconsin are susceptible to HAV infection and that most persons aged ≥35 who inject drugs are susceptible to HBV infection. In addition to routine vaccination of children, targeted hepatitis vaccination programs should focus on adults who inject drugs to help prevent future infections.

show abstract

Section: Discussionmentioning

confidence: 99%

Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection

et al. 2019

View full text Add to dashboard Cite

show abstract

“…These include concerns about the safety and effectiveness of vaccines and lack of information about the vaccines. [41][42][43] Strategies to help improve vaccination may include increased education [44][45][46][47][48][49] and development of vaccination policies specific to immunocompromised populations. [50][51][52] Health-care providers should also consistently incorporate the review of vaccine records into their practice.…”

Section: Discussionmentioning

confidence: 99%

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review

MacDonald

Palichuk

Slater

et al. 2021

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Immunocompromised children are at increased risk of severe illness from vaccine-preventable infections. However, inadequate vaccine coverage remains a concern. This scoping review sought to determine the current state of knowledge regarding vaccine coverage of immunocompromised children. Bibliographic databases were searched for primary research from any year. Data were analyzed quantitatively and narratively. Ninety-seven studies met inclusion criteria. The most commonly studied vaccines were pneumococcal (n = 46), influenza (n = 44), diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae type B/hepatitis B-containing (n = 36), and measles-and/or mumps-and/or rubella-containing (n = 29). Immunocompromising conditions studied included cancer/stem cell transplants (n = 24), solid organ transplants (n = 23), sickle cell disease (n = 21), immunosuppressive therapy (n = 14), human immunodeficiency virus (n = 12), splenectomy (n = 4), and primary immunodeficiency (n = 2). As more children are treated with immunosuppressive therapies, it is critical to identify whether they are being appropriately vaccinated for age and condition. We identified gaps in the current state of knowledge for specific vaccine types in specific immunocompromised populations.

show abstract

“…A recent study assessing the immunization status in children with sickle cell disease who were born in Michigan also observed that 29.1% of patients who received a full PCV7 series had not yet received a PCV13, which was slightly lower than what was observed in this study (40%). 12 However, this 40% does not exclude those patients who never received the PCV7 vaccination and are only missing the fourth PCV13 dose of the series. Similar to the MenB vaccine, administration of the PPSV23 vaccine is not a category A recommendation in otherwise healthy children, which may limit its availability in clinics as well as the provider's understanding of its importance for these patients.…”

Section: Discussionmentioning

confidence: 99%

“…Other studies have also looked to compare pneumococcal immunization rates in patients with sickle cell disease to non-sickle cell disease control groups. 11,12 Results from the studies conducted by both Nero et al 11 and Wagner et al 12 indicate that patients with sickle cell disease are more adherent to the immunization schedule versus the control groups, but they still have lower immunization rates than other state and national immunization surveys. In addition to studies that observe a lack of compliance among this patient population, adherence concerns are recognized throughout many hematologic clinics in the United States.…”

Section: Introductionmentioning

confidence: 99%

Immunization Adherence in Children With Sickle Cell Disease: A Single-Institution Experience

Infanti¹,

Elder²,

Franco³

et al. 2020

The Journal of Pediatric Pharmacology and Therapeutics

View full text Add to dashboard Cite

OBJECTIVES The Advisory Committee on Immunization Practices (ACIP) recommends additional immunizations for people with asplenia or functional asplenia, such as children with sickle cell disease. Adherence rate to the recommended immunization schedule for functional asplenia remains low for children with sickle cell disease. The purpose of this study was to assess the immunization adherence for this population at a single institution in Kentucky and to evaluate the use of the Kentucky Immunization Registry (KYIR) by providers. METHODS A single-center retrospective chart review was conducted for 107 children with sickle cell disease ages 2 through 18 years. Immunization histories were obtained from the hospital EMRs, the sickle cell clinic EMR, the KYIR, and by requesting records from primary care physicians. Each patient was documented as either missing or having complete records in the KYIR. RESULTS The complete adherence rate to the ACIP-recommended immunization schedule for children with functional asplenia was 6% (6 of 107). Nearly all children were compliant with the Haemophilus influenzae type B vaccination, whereas the adherence rate for the meningococcal and pneumococcal vaccines ranged from 25% to 77%. The lowest immunization rate was observed in children eligible for the meningococcal B vaccine (25%). Only 3 patients had a complete immunization history documented in the KYIR. CONCLUSIONS Adherence to the ACIP-recommended immunization schedule for functionally asplenic patients is poor among children with sickle cell disease included in this study. Quality improvement measures should focus on increasing immunization adherence and improving documentation of immunization records in the KYIR for this patient population.

show abstract

Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease

Cited by 11 publications

References 14 publications

Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection

Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review

Immunization Adherence in Children With Sickle Cell Disease: A Single-Institution Experience

Contact Info

Product

Resources

About